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ABSTRACT: Visceral leishmaniasis is a type of zoonosis caused by several Leishmania species 
endemic to tropical, subtropical, and Mediterranean climate regions. Dogs are the primary source of 
infection in urban areas and can be symptomatic or asymptomatic. This study focused on the 
observation of clinical signs of leishmaniasis in dogs in Campo Grande, Mato Grosso do Sul, Brazil. 
Samples from affected animals were analyzed using indirect fluorescent antibody (IFA) tests, an 
enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction (PCR) assays to 
determine the optimal diagnostic tool for use on animals that present clinical symptoms. A 
predominance of clinical symptoms affecting the integumentary system was observed, and 
splenomegaly and hepatomegaly were the most important pathological signs. Among the diagnostic 
tests, the greatest agreement was seen between ELISA and IFA, followed by ELISA and PCR, and 
finally IFA and PCR. PCR diagnostic results showed the greatest extent of correlation with clinical 
signs, followed by ELISA and then IFA. When choosing a diagnostic method, veterinarians should 
consider the clinical signs and health status of the patient. 
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DIAGNÓSTICO LABORATORIAL E SINAIS CLÍNICOS PARA LEISHMANIOSE 
VISCERAL CANINA EM CÃES EXAMINADOS NO CENTRO DE CONTROLE DE 
ZOONOSES DE CAMPO GRANDE – MS 
 
RESUMO: A Leishmaniose Visceral é uma zoonose causada por várias espécies de Leishmania, 
sendo endêmica em paises de áreas Tropicais, Subtropicais e do Mediterrâneo. O cão é a principal 
fonte de infecção em regiões urbanas, podendo também desenvolver a doença. Neste trabalho fez-
se a observação de sinais clínicos de cães da cidade de Campo Grande – MS, que foram 
posteriormente submetidos aos testes de RIFI, ELISA e PCR, objetivando avaliar qual deverá ser a 
técnica de diagnóstico a ser solicitada, quando o animal estiver apresentando determinados sinais 
clínicos. Pode-se observar um predomínio de sinais clínicos relacionados ao sistema tegumentar. Os 
sinais anatomopatológicos de maior importância foram a esplenomegalia e a hepatomegalia. Dentre 
os testes diagnósticos, houve maior concordância entre ELISA e RIFI, seguido por ELISA e PCR e, 
por fim, RIFI e PCR. Quanto à concordâncias com os sinais clínicos, o teste diagnóstico que 
apresentou maior correlação com cada um foi a PCR, logo depois o ELISA e, com menor correlação, 
apresentou-se a RIFI. Afirma-se que, o clínico veterinário, ao decidir por uma técnica de diagnóstico, 
deve considerar os sinais clínicos observados e o estado de saúde do paciente. 
Palavras-chave: ELISA, PCR, IFA, iniciadores RV1/RV2, Leishmaniose Visceral 
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INTRODUCTION 
 
Visceral leishmaniasis (VL) is a 
zoonotic disease caused by several 
Leishmania species (Ross, 1903), all of 
which belong to the subgenus 
Leishmania and the L. donovani and L. 
infantum complexes (Thomaz-Soccol et 
al., 1993). In the Americas and in 
Mediterranean regions, the species L. 
(L.) infantum is responsible for VL, which 
may affect humans who come into 
contact with the parasite transmission 
vectors. In the case of human 
transmission, the disease becomes an 
anthropozoonosis (Badaró, 1983).  
VL is endemic to several countries 
in tropical, subtropical, and 
Mediterranean climate regions, including 
India, Sudan, Bangladesh, Nepal, and 
Brazil, all of which have economically 
underdeveloped areas and socially 
impoverished populations. These 
countries account for approximately 90% 
of reported VL cases (Gontijo and Melo, 
2004; Chappuis et al., 2007). Mammals, 
including humans and wild animals (e.g., 
foxes, skunks, and rodents), are 
susceptible to VL infection, and in urban 
areas, VL primarily affects dogs that are 
bitten by the female phlebotomine sand 
fly (Lutzomia longipalpis), which is the 
vector species (Brasil, 2006; Gontijo and 
Melo, 2004).  
The first VL cases in Brazil were 
reported in 1934, and in 1936, Evandro 
Chagas described the first case in vivo. 
VL was recognized as endemic in 1953, 
with outbreaks most commonly 
occurring in Ceará, Bahia, Piauí, and 
Minas Gerais (Michalick, 2005; Genaro, 
1993). However, the epidemiological 
profile of VL in Brazil has been changing 
over time. Initially, the incidence of the 
disease was associated with poverty as 
well as canine and human malnutrition in 
rural or wild areas, such as in the 
Northeast region of Brazil. Currently, in 
the Southeast and Midwest regions of 
Brazil, the disease occurs in urban and 
peri-urban areas, which is indicative of 
the urbanization of the disease (Brasil, 
2006; Nunes et al., 1988). 
Although Campo Grande is a 
rapidly developing and expanding city, it 
nonetheless exhibits distinct rural 
features that facilitate the adaptation and 
subsequent urbanization of VL. For this 
reason, state and municipal health 
departments, particularly those with 
primary health care services and 
services for health care professionals 
responsible for educational programs, 
must actively search for and 
communicate with populations in high 
risk areas to reduce VL cases in humans 
and dogs (Borges et al., 2008). 
Canine visceral leishmaniasis 
(CVL) is a chronic disease and can be 
either symptomatic or asymptomatic. 
Symptomatic dogs may display apathy, 
alopecia, hair opacification, progressive 
weight loss, keratoconjuctivitis, facial 
dermatitis, nail stretching, nose and ear 
sores, swelling, and paresis of the hind 
paws. Asymptomatic animals are 
diagnosed through seropositivity. 
Depending on the stage of the disease 
and the immunological status of the 
animal, infected dogs can become 
important sources of Leishmania 
transmission (Gontijo and Melo, 2004; 
Silva et al., 2005; Costa et al., 2007). 
The diagnosis of CVL in dogs can 
be performed based on the animals’ 
clinical characteristics and can be 
confirmed by direct and indirect 
laboratory methods (Bonates, 2003). 
Direct methods of diagnosis include the 
visualization of the etiological agent in 
aspiration biopsies of lymphoid organs. 
Indirect methods are based on DNA 
testing and antibody detection using 
serological tests (Thomé, 1999; Feitosa 
et al., 2000). Currently, the Ministry of 
Health recommends the use of two 
serological tests: an enzyme-linked 
immunoabsorbent assay (ELISA) and an 
indirect fluorescent antibody (IFA) 
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assay. The IFA assay is the most 
commonly used routine diagnostic 
technique (Brasil, 2004). 
The goals of this study were to 
classify the clinical symptoms of CVL 
and compare the diagnostic efficacy of 
the serological tests (IFA and ELISA) 
and a polymerase chain reaction (PCR) 
assay using peripheral blood samples 
from dogs examined at the Center for 
Zoonosis Control in Campo Grande, 
Mato Grosso do Sul, Brazil, from 2009 to 
2010. 
 
MATERIAL AND METHODS 
 
Animals 
This study was conducted using 
200 dogs that were examined at the 
Center for Zoonosis Control (Centro de 
Controle de Zoonozes – CCZ) in the 
municipality of Campo Grande, Mato 
Grosso do Sul, Brazil. The animals’ 
owners submitted them to the center as 
the result of an intense educational 
campaign in the municipality on the 
importance of controlling leishmaniasis 
in dogs. The animals were examined for 
clinical signs and were classified into 
three groups according to their 
symptoms: asymptomatic (dogs in which 
no alterations were identified during a 
physical examination or by microscopic 
examination performed during autopsy), 
oligo-symptomatic (dogs that presented 
with up to three clinical symptoms, as 
revealed by physical examination, or 
that had up to three compromised 
organs), and symptomatic (dogs with 
more than three clinical symptoms, as 
revealed by physical examination, or 
which had more than three 
compromised organs). 
Indirect Immunofluorescence Test 
The IFA method is the “gold 
standard” for human leishmaniasis 
diagnosis and is also used for the 
diagnosis of CVL in veterinary medicine. 
Briefly, the IFA assay is based on the 
reaction of sera suspected of infection 
with parasites fixed on microscope 
slides. The readout is performed using a 
microscope equipped for the detection of 
ultraviolet excitation light. Sera are 
considered positive when the parasites 
show fluorescent staining around the 
periphery, with a cutoff titer of 1:40 (Bio-
Manguinhos/Fiocruz kit). The 
established standard titer range used 
here was 1:40 to 1:80. 
Enzyme-Linked Immunosorbent 
Assay 
The ELISA used for the diagnosis 
of CVL (Leishmania donovani complex) 
was developed by Avrameas et al. in 
1992 and modified by Laurentino-Silva 
(Bio-Manguinhos/Fiocruz kit). The result 
is typically obtained via the visual 
observation of a color change without 
the need for absorbance measurements. 
In the tests performed here, a titration 
ranging from 1:40 to 1:80 was used. 
Polymerase Chain Reaction Assays 
PCR reproduces in vitro the 
natural process of DNA replication and 
can be repeated on a large scale. For 
the development of primers, this 
methodology requires, at a minimum, 
partial knowledge of the target DNA of a 
particular organism (Yang and Rothman, 
2004).  
Blood samples were collected at 
the CCZ from dogs with a clinical 
suspicion of CVL or that were 
determined to be seropositive by ELISA 
and IFA. For each sample, 100 µL of 
blood and 900 µL of DNAzol were 
placed in 1.5-mL microtubes. The tubes 
were mixed thoroughly by inversion and 
centrifuged at 10,000 x g for 10 minutes. 
The supernatant of each tube was 
transferred to a clean tube, 1 mL of pure 
ethanol was added, and the sample was 
centrifuged for 3 minutes at 4,000 x g. 
The precipitate was washed with 75% 
ethanol, centrifuged at 13,000 x g for 5 
minutes, allowed to dry, and redissolved 
in 50 µL of water. The purity and 
concentration of the DNA were 
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determined by measuring the optical 
density using a spectrophotometer 
(NanoDrop® ND-1000 UV-Vis) and by 
agarose gel electrophoresis. 
A temperature curve was used to 
determine the optimal annealing 
temperature for the primers for the 
standardization of the PCR. The positive 
control, strain L. chagasi 
(MHOM/BR/74/PP/75), was provided by 
the Leishmaniasis Research Laboratory 
at the René Rachou/Fiocruz Research 
Center (Belo Horizonte, Brazil). 
Ultrapure water was used instead of 
DNA as the negative control. The 
following primers were used: RV1-
CTTTTCTGGTCCCGCGGGTAGG and 
RV2- CACCTGGCCTATTTTACACCA. 
These primers were expected to 
generate a 145-bp product (Lachaud et 
al., 2002). 
The initial PCR was performed at 
a final volume of 25 μL containing 1 μL 
of DNA (40 – 100 ng/µL), 1x buffer, 0.2 
mM dNTPs, 1.5 mM MgCl2, 0.16 pmol of 
each primer RV1 and RV2, 2 U Taq 
polymerase, and water up to the final 
volume. Samples were amplified using a 
Eppendorf Mastercycler® Personal with 
standard cycles. Verification of the 145-
bp DNA fragment was performed using 
10 μL of PCR product in a 4% agarose 
gel with tris-acetate-EDTA (TAE) pH 8.0. 
Gels were stained with ethidium bromide 
(0.5 mg/mL) and visualized using a UV 
transilluminator. 
Statistical Analyses 
The results of the diagnostic 
analyses and the clinical symptoms of 
the animals were tested for pair-wise 
agreement based on the frequency 
distribution of each test and each clinical 
symptom. The following criteria were 
used to conceptualize the results in 
terms of their agreement: values ≤ 40% 
were considered poor; 40.1 to 79.9% 
was regular; 80 to 89.9% was good; and 
≥ 90% was considered excellent. The 
results obtained using the diagnostic 
techniques were analyzed using the 
Kappa coefficient test. The p values 
were calculated using the McNemar test 
to establish the significance (p<0.05) of 
the Kappa test. 
 
RESULTS  
 
Clinical symptoms and pathological 
changes 
This study identified 37 
asymptomatic dogs, 62 oligo-
symptomatic dogs, and 101 
symptomatic dogs. The primary 
symptoms were weight loss (40%), 
onychogryphosis (39%), pinna dermatitis 
(31%), and lymphadenopathy (29.0%). 
Less common symptoms were 
splenomegaly (18%), conjunctivitis 
(17.5%), peeling (15.5%), skin laceration 
(12%), myotrophies (11.5%), alopecia 
(11.5%), and dermatitis (10%). Other 
clinical symptoms occurred in less than 
10% of the animals (Figure 1). 
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Diagnostic tests 
IFA assays identified 160 dogs 
(80%) that were positive for 
leishmaniasis, whereas 130 (65%) and 
95 (47.5%) cases were identified using 
ELISA and PCR, respectively. According 
to all three diagnostic tests, 65 animals 
were positive (32.5%) and 25 were 
negative (12.5%). 
 
 
The comparison of IFA, ELISA, 
and PCR diagnostic test results, 
including the percent agreement 
percentages, Kappa coefficients, and p 
values, are shown in Table 1. 
 
 
Diagnostic results compared to 
clinical symptoms 
The group of asymptomatic dogs 
had the lowest number of animals (37) 
and the least number of positive results 
according to all three tests: 29 (14.5%) 
cases by IFA, 26 (13%) by ELISA, and 
17 (8.5%) by PCR. Among the group of 
62 oligo-symptomatic dogs, 57 (28.5%) 
were diagnosed by IFA, 47 (23.5%) by 
ELISA, and 31 (15.5%) by PCR. The 
largest number of positive results (101 
animals) was observed for the 
symptomatic group, of which 74 (37%) 
were seropositive by IFA, 57 (28.5%) 
were identified by ELISA, and 47 
(23.5%) were indicated by PCR. This 
group also had the highest percentage 
of positive diagnoses of CVL. 
The frequency of positive results 
for each diagnostic test among the 
asymptomatic, oligo-symptomatic, and 
symptomatic groups is shown in Table 2. 
 
 
 
Asymptomatic Dogs 
Table 3 shows the comparative 
data for the diagnostic tests (IFA, ELISA, 
and PCR) performed using the 
peripheral blood of asymptomatic dogs; 
the percent agreement, Kappa 
coefficient and p value results are 
reported. In this group, 13 (35%) of the 
animals were positive, and 5 (13.5%) 
were negative in all three diagnostic 
tests performed. Of the remaining 
animals, only a single type of test 
indicated a positive result in a total of 5 
cases: 3 were positive only by IFA, 1 
was only positive according to ELISA, 
and 1 was identified by PCR alone. 
Similarly, 1 animal was negative only 
according to IFA, whereas 2 and 11 
cases were negative only according to 
ELISA and PCR results, respectively. 
The agreement within this group was 
48.5% among the three tests. 
 
 
 
Oligo-symptomatic dogs 
The comparison of IFA, ELISA, 
and PCR test results obtained using the 
peripheral blood of oligo-symptomatic 
dogs is presented in Table 4, which 
includes the percent agreement, Kappa 
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coefficient, and p value results. In this 
group, 24 (38.7%) dogs were positive 
and 4 (6.4%) were negative according to 
the IFA, ELISA, and PCR tests. In 
addition, 4 animals were positive only by 
ELISA, and 1 was positive by PCR only; 
6 were negative by ELISA only, and 23 
were negative according to PCR only. In 
this group, the agreement among the 
three diagnostic tests was 45.1%. 
 
 
 
Symptomatic dogs 
The data comparing the results of 
the IFA, ELISA, and PCR diagnostic 
tests using peripheral blood collected 
from symptomatic dogs are shown in 
Table 4, including the percent 
agreement, kappa coefficient, and p 
value results. In this group, 28 (27.7%) 
of the animals were positive and 16 
(15.8%) were negative for all three 
diagnostic tests. A total of 9 animals 
were positive only by IFA and 11 were 
positive only by PCR; 8 animals were 
negative only by ELISA and 29 were 
negative only by PCR. This group 
showed 43.5% agreement among the 
three diagnostic tests. 
 
 
 
Diagnostic test results compared to 
clinical manifestations 
The clinical symptoms most 
commonly observed during the clinical 
examinations of the animals are shown 
in Table 6. In this table, each clinical 
symptom is correlated with each of the 
three diagnostic tests in a pair-wise 
comparison. The percent agreement 
between each clinical symptom and the 
respective diagnostic test was calculated 
to determine the most accurate 
diagnostic test to be used when a 
clinical symptom is presented. The 
Kappa test indicates the magnitude of 
this correlation, and the p value 
indicates the significance of the Kappa 
test. 
 
 
 
 
DISCUSSION 
 
A predominance of clinical 
symptoms related to the integumentary 
system was observed, and 127 of 200 
(63.5%) animals presented symptoms 
related to this system. Considering only 
those animals that showed clinical 
symptoms (163), the presence of clinical 
symptoms associated with the 
23 
Cunha et al. (2012) 
 
 
Archives of Veterinary Science, v.17, n.4, p.17-26, 2012. 
integumentary system was observed in 
127 of 163 (78%) animals, which was a 
highly significant occurrence. Of these, 
59 of 127 (46.5%) presented 1 clinical 
symptom, 42 of 127 (33.1%) presented 
2 clinical symptoms, 21 of 127 (16.5%) 
had 3 clinical symptoms, and 5 of 127 
(4%) had more than 3 clinical symptoms 
associated with the integumentary 
system. Thus, the observation of these 
symptoms by the veterinarian is of 
paramount importance in cases of 
suspicion of CVL and these symptoms 
are important for the diﬀerential 
diagnosis of demodicosis. 
The most important pathological 
symptoms were splenomegaly and 
hepatomegaly, which were present in 36 
(18%) and 15 (7.5%) of the 200 studied 
dogs, respectively. Of all the animals 
that showed hepatomegaly, only one did 
not present concurrent splenomegaly. 
Therefore, we believe that 
hepatomegaly occurs after 
splenomegaly and depends on disease 
progression. 
Other commonly presented 
clinical symptoms were presented: 
weight loss in 80 of 200 (40%) dogs; 
lymphadenopathy in 58 of 200 (29.0%) 
dogs; and conjunctivitis in 35 of 200 
(17.5%) of dogs. Other clinical 
symptoms were not as common. The 
great variability of clinical manifestations 
of CVL may be due to the genetic 
characteristics of each dog, which also 
determine the different immune 
responses seen in these animals. 
Additionally, some animals or breeds 
can be more resistant than others, 
thereby determining the disease 
susceptibility (Solano-Gallego et al., 
2000). 
In the diagnostic assays, 90 of 
200 dogs were positive for all three 
diagnostic tests with 45% agreement 
among the tests. According to the Kappa 
tests for the pairwise comparisons, there 
was a greater agreement between 
ELISA and IFA, followed by ELISA and 
PCR, and finally IFA and PCR. 
Using only the ELISA diagnostic 
test, 130 (65%) samples were positive 
for CVL. When combined, ELISA and 
IFA increased the positive sample 
detection rate by 16% (32 of 200) for a 
total of 81% (162 of 200). If the PCR 
results were included, there was a 
12.5% increase (25 of 200) for a total 
detection rate of 93.5% (187 of 200) of 
the CVL-positive samples. Therefore, 
the use of two or more techniques is 
recommended for the epidemiological 
control of canine leishmaniasis. 
The symptomatic dog group, with 
a total of 101 animals (50.5%), 
comprised the largest group identified in 
this study. All three tests proved to be 
effective for this group. Accordingly, the 
symptomatic group showed the highest 
positive rate in the diagnostic tests, 
followed by the oligo-symptomatic and 
asymptomatic groups. Independent of 
the clinical group, IFA showed the 
highest positive rate for the diagnosis of 
CVL, followed by ELISA, and then PCR. 
The better performance of serological 
tests for diagnosing CVL can be 
explained by the high polyclonal 
stimulation of B lymphocytes caused by 
leishmaniasis, which leads to 
hypergammaglobulinemia and the 
extensive production of antibodies that 
facilitate diagnosis by these tests 
(Feitosa et al., 2000). 
ELISA is a relatively quick and 
simple test but requires trained 
personnel and specialized, expensive 
equipment. This test is sensitive; i.e., it 
allows for the detection of low titers of 
antibodies with a sensitivity of greater 
than 98% (Rey, 2001,Thomaz-Soccol et 
al., 2009). IFA is now considered the 
test of choice by the Brazilian Ministry of 
Health in canine sero-surveys and 
exhibits 90% to 100% sensitivity and a 
specificity of approximately 80% in sera 
samples. Additionally, ELISA is a 
relatively easy test to perform with fast 
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results and a low cost (Alves and 
Bevilacqua, 2004). However, there has 
been disagreement in the literature 
regarding the need for two or more 
diagnostic methods to increase rate of 
correct diagnosis of leishmaniasis 
(Szargiki et al., 2009). 
When compared to clinical 
symptoms, the PCR-based diagnostic 
test showed the greatest correlation, 
with 45% to 55% agreement with each 
clinical symptom, followed by ELISA, 
with 34.5% to 54.5% agreement. The 
lowest correlation was observed for IFA 
with 26% to 47% agreement with each 
clinical symptom. In other words, the test 
with the highest positive result rate, IFA, 
was the method with the lowest extent of 
correlation with clinical signs. In 
contrast, the test with the lowest positive 
rate, PCR, had the highest correlation 
with clinical signs. However, it is known 
that low levels of parasitemia in infected 
animals can contribute to low detection 
rates by PCR in blood samples, as 
reported by Fisa et al. (2001). The PCR 
technique could be improved if samples 
were collected from the popliteal lymph 
node or the leukocyte layer because 
these would house greater numbers of 
parasites, thereby increasing the 
sensitivity of detection. 
The correlation results of the tests 
used in this study support those of other 
recent studies, such a report by as 
Lachoud et al. (2002), who motivated 
Gomes et al. (2007) to conduct a study 
to verify the ability of PCR (RV1/RV2) to 
diagnose CVL in different tissue 
samples from dogs in the State of São 
Paulo, Brazil. In another study 
conducted with 95 dogs in Italy, Manna 
et al. (2004) reported a 94% positive 
rate using PCR, with 4 animals positive 
by PCR that were negative according to 
other serological tests. In this present 
study, 13 of 200 (6.5%) animals were 
positive by PCR and negative by other 
diagnostic tests. 
In this study, PCR proved to be 
the safest and most cost-effective test 
relative to the serological tests (IFA and 
ELISA), which have been shown to have 
several disadvantages, including the 
difficulty in differentiating between 
current and previous parasitic infections. 
Additionally, it is not possible to correlate 
the levels of circulating antibodies with 
the disease stage using IFA and ELISA, 
and the cost of producing specific 
purified antigens can be prohibitively 
high. Consequently, preparations with 
crude antigens are often used, thereby 
reducing the specificity and sensitivity of 
these tests (Green, 2006) and 
generating a relatively high false positive 
rate. 
In veterinary medicine, the 
clinician is often confronted with cases 
suggestive of certain canine diseases, 
although diagnostic tests can indicate 
contradictory results (Francino et al., 
2006). In this study, PCR showed the 
lowest percentage of contradictory 
results when compared with observed 
clinical signs. Therefore, this article can 
serve as a tool to help veterinary doctors 
select a diagnostic technique while 
taking into account the observed 
symptoms and the patient status. 
 
CONCLUSION 
 
In this study, we used a relatively 
large number of dogs (200) for the 
clinical and laboratory evaluation of 
CVL. The objective of classifying dogs 
using clinical symptoms and the 
comparison of IFA, ELISA, and PCR 
tests was achieved. However, even with 
this representative sample number, the 
results support previous findings that 
demonstrate that no one diagnostic test 
is capable of properly identifying dogs 
with CVL when used alone. Although 
PCR showed the greatest correlation 
with the presence of clinical symptoms, 
our results clearly demonstrated that a 
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negative result based on a single type of 
test can be misleading and may instead 
represent a false negative result. These 
results stress the need to employ a 
combination of diagnostic techniques. 
However, when a strong clinical 
suspicion is present, our results show 
that PCR is essential for reaching a 
definitive diagnosis. Finally, 
veterinarians should always consider the 
clinical symptoms and health status of 
the patient when selecting a diagnostic 
test. 
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